tenk.fyi

Apogee Therapeutics, Inc.

APGENasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$255.8M

40.5% YoY

EPS

$-4.22

27.9% YoY

Cash

$131.5M

7.2% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade